Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Michael Michael

Showing results (151-160 of 216) with videos related to

Pageof 22
Sort By:
Langenbeck'S Archives of Surgery|October 10, 2023
Use of patient-derived explants as a preclinical model for precision medicine in colorectal cancer: A scoping reviewMilton Mui, Molly Clark, Tamara M S H Vu, et al.
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology|October 16, 2020
Results of phase II trial of intensified neoadjuvant treatment with interdigitating radiotherapy and chemotherapy with oxaliplatin, 5-fluorouracil and folinic acid in patients with locally advanced rectal cancer (PROARCT trial)Sweet Ping Ng, Julie Chu, Sarat Chander, et al.
Clinical Drug Investigation|October 27, 2025
Cost-Effectiveness of Pre-emptive DPYD Genotyping Compared to Standard of Care Among Patients Receiving Fluoropyrimidine-Based Anti-cancer Treatment in AustraliaSarah Glewis, Mussab Fagery, Senthil Lingaratnam, et al.
Surgical Oncology|April 11, 2021
Outcomes following synchronous liver resection, cytoreductive surgery and hyperthermic intraperitoneal chemotherapy for colorectal liver and peritoneal metastases: A bi-institutional studyMichael P Flood, Peadar S Waters, Michael E Kelly, et al.
Endocrine Oncology (Bristol, England)|December 9, 2024
Peptide receptor radionuclide therapy for ectopic Cushing's syndrome caused by metastatic neuroendocrine neoplasmsEmma Boehm, Terry Hung, Tim Akhurst, et al.
British Journal of Clinical Pharmacology|January 4, 2026
The utility of genomics and functional imaging to predict sunitinib pharmacokinetics and pharmacodynamics: The predict SU studyMichael Michael, Guy C Toner, Vinod Ganju, et al.
JAMA Oncology|July 31, 2020
Evaluation of Combination Nivolumab and Ipilimumab Immunotherapy in Patients With Advanced Biliary Tract Cancers: Subgroup Analysis of a Phase 2 Nonrandomized Clinical TrialOliver Klein, Damien Kee, Adnan Nagrial, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|May 29, 2021
Efficacy and Safety of <sup>177</sup>Lu-DOTATATE in Lung Neuroendocrine Tumors: A Bicenter studyLamiaa Zidan, Amir Iravani, Kira Oleinikov, et al.
British Journal of Clinical Pharmacology|February 24, 2025
Feasibility and population exposure of 5-fluorouracil using therapeutic drug monitoring (PREDICT-5FU): A multicentre clinical trialSarah Glewis, Michael Michael, Howard Gurney, et al.
ANZ Journal of Surgery|April 29, 2026
Timeliness of Care and Treatment Patterns for Pancreatic Cancer in Victoria, Australia: Comparison With Optimal Care Pathways TargetsSam Banks, Belinda Lee, Nadia Ayres, et al.
Pageof 22

Showing results (151-160 of 216) with videos related to

Sort By:
Pageof 22
Langenbeck'S Archives of Surgery|October 10, 2023
Use of patient-derived explants as a preclinical model for precision medicine in colorectal cancer: A scoping reviewMilton Mui, Molly Clark, Tamara M S H Vu, et al.
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology|October 16, 2020
Results of phase II trial of intensified neoadjuvant treatment with interdigitating radiotherapy and chemotherapy with oxaliplatin, 5-fluorouracil and folinic acid in patients with locally advanced rectal cancer (PROARCT trial)Sweet Ping Ng, Julie Chu, Sarat Chander, et al.
Clinical Drug Investigation|October 27, 2025
Cost-Effectiveness of Pre-emptive DPYD Genotyping Compared to Standard of Care Among Patients Receiving Fluoropyrimidine-Based Anti-cancer Treatment in AustraliaSarah Glewis, Mussab Fagery, Senthil Lingaratnam, et al.
Surgical Oncology|April 11, 2021
Outcomes following synchronous liver resection, cytoreductive surgery and hyperthermic intraperitoneal chemotherapy for colorectal liver and peritoneal metastases: A bi-institutional studyMichael P Flood, Peadar S Waters, Michael E Kelly, et al.
Endocrine Oncology (Bristol, England)|December 9, 2024
Peptide receptor radionuclide therapy for ectopic Cushing's syndrome caused by metastatic neuroendocrine neoplasmsEmma Boehm, Terry Hung, Tim Akhurst, et al.
British Journal of Clinical Pharmacology|January 4, 2026
The utility of genomics and functional imaging to predict sunitinib pharmacokinetics and pharmacodynamics: The predict SU studyMichael Michael, Guy C Toner, Vinod Ganju, et al.
JAMA Oncology|July 31, 2020
Evaluation of Combination Nivolumab and Ipilimumab Immunotherapy in Patients With Advanced Biliary Tract Cancers: Subgroup Analysis of a Phase 2 Nonrandomized Clinical TrialOliver Klein, Damien Kee, Adnan Nagrial, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|May 29, 2021
Efficacy and Safety of <sup>177</sup>Lu-DOTATATE in Lung Neuroendocrine Tumors: A Bicenter studyLamiaa Zidan, Amir Iravani, Kira Oleinikov, et al.
British Journal of Clinical Pharmacology|February 24, 2025
Feasibility and population exposure of 5-fluorouracil using therapeutic drug monitoring (PREDICT-5FU): A multicentre clinical trialSarah Glewis, Michael Michael, Howard Gurney, et al.
ANZ Journal of Surgery|April 29, 2026
Timeliness of Care and Treatment Patterns for Pancreatic Cancer in Victoria, Australia: Comparison With Optimal Care Pathways TargetsSam Banks, Belinda Lee, Nadia Ayres, et al.
Pageof 22